Skip to main content

Table 2 Surgical outcomes of patients of included studies

From: Radical antegrade modular pancreatosplenectomy versus standard procedure in the treatment of left-sided pancreatic cancer: A systemic review and meta-analysis

References

Group

Intraoperative blood loss(ml)

Operative time (min)

Lymph node harvested

Complication

R0 resection

Combined resection

Hospital stay (days)

Recurrence

HR(95% CI) for DFS

HR(95% CI) for OS

Latorre [28]

RAMPS

342

315

20.7 ± 8.9

2

7(87.5%)

4

12.1

NA

1.32

(0.45–3.92)

1.26

(0.45–3.57)

Standard

369

265

16.2 ± 4.2

5

15(88.2%)

9.9

NA

Park [24]

RAMPS

325 (50–3400)

210 (125–480)

14(5–52)

7

34(89.5%)

15

11.5(7–32)

25(65.6%)

NA

0.56

(0.32–0.98)

Standard

400 (50–3300)

185 (80–390)

9(1–36)

12

46(85.2%)

11

10.7(6–42)

35(64.8%)

Trottman [27]

RAMPS

500.0 ± 260.8

300.0 ± 87.0

11.2 ± 6.0

3

6(100%)

NA

7.7 ± 3.0

NA

NA

NA

Standard

581.3 ± 559.2

295.3 ± 83.8

4.3 ± 5.4

12

19(95%)

NA

6.9 ± 1.4

NA

Abe [20]

RAMPS

485.4 ± 63.3

267.3 ± 11.5

28.4 ± 11.6

19

48(90.6%)

8

35.7 ± 19.6

32(60.4%)

0.96

(0.54–1.71)

0.66

(0.21–2.11)

Standard

682.3 ± 72.8

339.4 ± 13.2

20.7 ± 10.1

14

27(67.5%)

5

26.7 ± 25.5

30(75.0%)

Xua [29]

RAMPS

400(350–650)

235(180–278)

NA

16

19(90.5%)

13

15(13–23)

6(33.3%)

NA

NA

Standard

225(200–400)

180(130–210)

NA

48

71(91.0%)

10

12(10–16)

31(45.6%)

Kimb [30]

RAMPS

300 ± 220

277.8 ± 55.6

21.5 ± 8.3

14

22(84.6%)

NA

6.4 ± 4.3

8(30.8%)

0.90

(0.08–9.92)

0.48

(0.13–1.83)

Standard

260 ± 180

253.3 ± 41.0

13.7 ± 7.4

8

11(64.%7)

NA

8.2 ± 3.3

8(47.1%)

  1. NA not available. aThree and 10 patients in RAMPS and standard group were loss of follow-up (median 18 months, range 5–37 months) in the study period. bTwo patients who had neuroendocrine carcinoma and two who had metastatic renal cell carcinoma in RAMPS group and two patients who had neuroendocrine carcinoma in standard group were excluded from the analyses of R0 and recurrence rate